- Aster Chronic [email protected] and Novartis enter into an innovative healthcare partnership in order to provide diabetes management across various sections of the society
- Novartis offers to sponsor 500 diabetic patients enrolled under Aster Chronic [email protected] service in the region
Dubai, United Arab Emirates, 14 November, 2017: Aster Chronic [email protected] joined forces with global pharmaceutical giant Novartis to sponsor 500 diabetic patients in the region, in recognition of their continued commitment to creating awareness and making disease management an easy process through innovative solutions. Aster Chronic [email protected] is an advanced personalized technology introduced by Aster DM Healthcare catering to improve individual control over chronic conditions like diabetes and hypertension.
The first of its kind, this corporate partnership grants 500 diabetic patients from across the region to register under Aster Chronic [email protected] This partnership comes as a relief for those who are unable to access highly advanced machines and telehealth services. The registrants are provided with Diabetes and Blood Pressure monitoring devices, constant care monitoring and fast track services free of cost for one year. Upon conclusion of the free 1 year service, the patients will be provided service renewal at special discounted costs. Aster Chronic [email protected] Home has already registered 100+ participants under the Novartis sponsorship.
As per reports from the International Diabetes Federation (IDF) 415 million people in the world suffer from diabetes, out of which 35.4 million constitute the MENA region, these figures are estimated to rise to 72.1 million by the year 2040. Sedentary lifestyles, unhealthy dietary practices, obesity, etc. are the most common risk factors leading to the rise in the number of diabetics in the region. The situation demands prompt intervention from healthcare players from private and public sectors.
“We constantly strive towards strengthening the healthcare service offerings while bridging the gap in access to quality healthcare across the UAE, and initiate positive measures to transform healthcare delivery in the country. Like all sectors, healthcare in the region is changing and moving towards integration of new age technology in order to provide solutions to healthcare challenges. Our utmost priority is to cater to the needs of the community we serve, and for the consumers today it’s all about access to everything made easy at their fingertips. At Aster DM Healthcare, we believe healthcare is about empowering the consumer and allowing them to take control of their health. Smart technology interventions in healthcare focuses on driving continuity of care, reducing any care gaps and ensuring preventive care which is crucial in chronic conditions like diabetes,” said Ms. Alisha Moopen, Executive Director and CEO, Hospitals and Clinics (GCC).
“Aster Chronic [email protected] is an innovative monitoring program delivering personalized healthcare solutions and empowering people to take control of their condition. Aster DM Healthcare and Novartis have entered into this association in order to deliver greater accessibility of healthcare services to people across all sections of the society. We are thrilled to be associating with a brand that shares our dedication to create awareness about chronic health conditions and improve the lives of people we serve every day,” she concluded.
“We consider Aster DM Healthcare an ideal healthcare partner as they echo our objective of providing newer ways to improve the lives of people. This era of constant connectivity requires adoption of digital technology at all levels and the growing demands for personalized disease management, calls for providing consumers with customized health services that are accessible and responsive. Aster Chronic [email protected] is a unique technological solution that combines constant connectivity and continuous chronic care management, allowing people to interact with Aster specialists from the convenience of their homes. Aster DM Healthcare has indeed elevated the level of diabetes management by shifting focus from exclusive hospital-based care. We look forward to more such unique associations with Aster DM Healthcare,” said Mr. Mohamed Ezz Eldin, Head of Gulf Countries at Novartis.
Aster Chronic [email protected] is an advanced technology combining the concept of constant connectivity, advanced smart-device technology, remote chronic care management from home and continuum of care. The programme aims to help people effectively manage Diabetes and Hypertension to live healthier, longer and quality lives, with focus on empowering patients to take control, with shared responsibility, employing latest technology across a vast network of practitioners and clinics under Aster DM Healthcare. Aster Chronic [email protected] Home won the ‘Asian Hospital Management Award’ under the category of ‘Best Hospital Innovation Methodology to Manage Chronic Disease Patients’ out of 418 entries from 102 hospitals in 17 countries.
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis is a global healthcare company that addresses the evolving needs of patients worldwide. Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. Novartis Pharmaceuticals commercializes innovative, patented primary care and specialty medicines to enhance health outcomes for patients and healthcare providers.
About Aster DM Healthcare
Aster DM Healthcare is a healthcare network with over 316 operating facilities across 9 countries, including 19 hospitals, 95 clinics & 202 retail pharmacies. The organization has 19,615 employees including 2161 full-time doctors as of May 30, 2017.